Getting this right enhances our ability to study specific
regions of the genome, helping us to gain further
insights into leukaemia biology and ultimately
discover novel ways it may be targeted. ​

Together with @avmoorman.bsky.social, we will lead the two research projects that will explore the biology of ALL and how we can use that information to find the most effective treatments and reduce the challenging long-term side effects of chemotherapy.

Two research projects at Newcastle University are celebrating £4.1million of investment from Cancer Research UK to explore how children with ALL, the same cancer Dan had, can be diagnosed and treated more effectively to improve survival rates.

Dr Brittain says "I am really excited to have joined
the @ljrusselllab.bsky.social group within @nucancer.bsky.social. I look
forward to applying the variety of cutting-edge
epigenomic techniques used within the group as we
continue to deepen our understanding of super-
enhancer biology"

It even made the News and Views section on the Nature website which provides a lovely overview of the paper. [https://nature.com/articles/d41586-025-02421-0].

Read it 👉[https://rdcu.be/ezAx6]
Supported by @littleprincesses.bsky.social @bloodcanceruk.bsky.social and VIVO Biobank.